These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31189201)

  • 1. Overview of Kybella (Deoxycholic Acid Injection) as a Fat Resorption Product for Submental Fat.
    Liu M; Chesnut C; Lask G
    Facial Plast Surg; 2019 Jun; 35(3):274-277. PubMed ID: 31189201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATX-101 (Deoxycholic Acid Injection) Treatment in Men: Insights From Our Clinical Experience.
    Shridharani SM; Behr KL
    Dermatol Surg; 2017 Nov; 43 Suppl 2():S225-S230. PubMed ID: 28902021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of ATX-101 (Deoxycholic Acid Injection): A Nonsurgical Approach for Reduction of Submental Fat.
    Dayan SH; Humphrey S; Jones DH; Lizzul PF; Gross TM; Stauffer K; Beddingfield FC
    Dermatol Surg; 2016 Nov; 42 Suppl 1():S263-S270. PubMed ID: 27787266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATX-101 (deoxycholic acid injection) for reduction of submental fat.
    Ascher B; Fellmann J; Monheit G
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1131-43. PubMed ID: 27457304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Patient Experience With ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat.
    Dover JS; Kenkel JM; Carruthers A; Lizzul PF; Gross TM; Subramanian M; Beddingfield FC
    Dermatol Surg; 2016 Nov; 42 Suppl 1():S288-S299. PubMed ID: 27787269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development, evidence, and current use of ATX-101 for the treatment of submental fat.
    Georgesen C; Lipner SR
    J Cosmet Dermatol; 2017 Jun; 16(2):174-179. PubMed ID: 28429841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium Deoxycholate for Submental Contouring.
    Humphrey S; Beleznay K; Beleznay JD
    Skin Therapy Lett; 2016 Sep; 21(5):1-4. PubMed ID: 27603325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proper Technique for Administration of ATX-101 (Deoxycholic Acid Injection): Insights From an Injection Practicum and Roundtable Discussion.
    Jones DH; Kenkel JM; Fagien S; Glaser DA; Monheit GD; Stauffer K; Sykes JM
    Dermatol Surg; 2016 Nov; 42 Suppl 1():S275-S281. PubMed ID: 27787267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Deoxycholic Acid for the Clinical Reduction of Excess Submental Fat in Indian Patients.
    Shome D; Khare S; Kapoor R
    J Drugs Dermatol; 2019 Mar; 18(3):266-272. PubMed ID: 30909331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of localized submental fat treatment with sodium deoxicolate (ATX-101).
    Ibáñez-Vicente C; Carrato-Gomez M; Meccariello L; Ripani U; Bisaccia M
    Med Glas (Zenica); 2021 Feb; 18(1):148-152. PubMed ID: 33655744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deoxycholic Acid: A Review in Submental Fat Contouring.
    Deeks ED
    Am J Clin Dermatol; 2016 Dec; 17(6):701-707. PubMed ID: 27785706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATX-101 for reduction of submental fat: A phase III randomized controlled trial.
    Humphrey S; Sykes J; Kantor J; Bertucci V; Walker P; Lee DR; Lizzul PF; Gross TM; Beddingfield FC
    J Am Acad Dermatol; 2016 Oct; 75(4):788-797.e7. PubMed ID: 27430612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction.
    Jones DH; Carruthers J; Joseph JH; Callender VD; Walker P; Lee DR; Subramanian M; Lizzul PF; Gross TM; Beddingfield FC
    Dermatol Surg; 2016 Jan; 42(1):38-49. PubMed ID: 26673433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive approach to treatment of submental fullness.
    Shah GM; Greenberg JN; Tanzi EL; Monheit GD
    Semin Cutan Med Surg; 2017 Dec; 36(4):164-169. PubMed ID: 29224033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional thoughts on the new treatment Kybella.
    Cohen JL; Chen DL; Green JB; Joseph JH
    Semin Cutan Med Surg; 2015 Sep; 34(3):138-9. PubMed ID: 26682336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Submental Deoxycholic Acid Injections on Neck Surgery.
    Lin MJ; Dubin DP; Schwarcz RM; Khorasani H
    J Drugs Dermatol; 2019 Dec; 18(12):1281. PubMed ID: 31860219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Trends in Management of Submental Liposis: A Pooled Analysis and Survey.
    Patel S; Kridel R
    JAMA Facial Plast Surg; 2018 May; 20(3):202-206. PubMed ID: 29049615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATX-101 (Deoxycholic Acid Injection) Leads to Clinically Meaningful Improvement in Submental Fat: Final Data From CONTOUR.
    Behr K; Kavali CM; Munavalli G; Teller CF; Yoelin S; Breshears L; Sangha S
    Dermatol Surg; 2020 May; 46(5):639-645. PubMed ID: 31517654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Expanded Safe Zone for Reduction of Submental Fullness with ATX-101 Injection.
    Shridharani SM; Chandawarkar AA
    Plast Reconstr Surg; 2019 Dec; 144(6):995e-1001e. PubMed ID: 31764639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxycholic Acid (ATX-101) for Reduction of Submental Fat.
    Dunican KC; Patel DK
    Ann Pharmacother; 2016 Oct; 50(10):855-61. PubMed ID: 27340142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.